Since the publication of the above article the authors have identified an error in the labelling of Figure 4c and in the listing of the siRNA sequence of BI-1 in the Materials and Methods section.
Shown here is the corrected version of Figure 4c -BI-1, and Neo labelling has been reversed.
The below paragraph from the Materials and Methods section of the paper has been amended to correct the listing of the siRNA sequence for BI-1.
siRNA transfection The siRNAs were synthesized in duplex and purified forms using Bioneer technology (Daejon, South Korea). The double-strand small interfering RNAs (siRNAs) targeting BI-1 (for BI-1 siRNA, 5′-GUGCUAUCCUACGAAAUCA-3′ (forward) and 5′-UGAUUUC GUAGGAUAGCAC-3′ (reverse); for non-specific siRNA, 5′-CUGA ACAACCAAUGCAAAU-3′ (forward) and 5′-AUUUGCAUUGGUUGU UCAG-3′ (reverse)) were transfected separately or together into Neo and BI-1 cells using Amaxa Nucleofector (Amaxa, Gaithersburg, MD, USA). Briefly, confluent cells were trypsinized and resuspended in Amaxa Nucleofector solution at 2 × 10 5 cells per 100 μl of solution, and BI-1 or on-specific siRNA was added. Cells were transfected by electroporation using the A24 pulsing program. 
